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Graphene is a flat monolayer of carbon atoms, arranged in a two-dimensional hexagonal structure, with extraordinary
electrical, thermal, and physical properties. Moreover, the molecular structure of graphene can be chemically modified
with molecules of interest to promote the development of high-performance devices. Although carbon derivatives
have been extensively employed in industry and electronics, their use in regenerative medicine is still in an early phase.
Study prove that graphene is highly biocompatible, has low toxicity and a large dosage loading capacity. This review
describes the ability of graphene and its related materials to induce stem cells differentiation into osteogenic, neuronal,
and adipogenic lineages.
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An outburst of research on regenerative medicine has re-
cently emerged to develop nanostructured materials as
smart interfaces to be used for cellular studies and regen-
erative medicine. Tissue regeneration is a demanding field
in terms of development of biomaterials since it requires a
variety of fabrication scales, ranging from signal transduc-
tion levels to macroscopic tissue recapitulation. Current
nanoscale research is focusing primarily on new materials
that might be manufactured at high production volume
and thus be associated with significant human application.
The final goal is a better understanding of the complexity
that entails the native extracellular matrix (ECM) through
the creation of in vitro models, leading to engineered
scaffolds specifically designed to modulate cells differenti-
ation. Many authors have demonstrated that cell shape,
morphology, attachment, proliferation, and migration can
be controlled by cell-material interactions [1-4]. The rele-
vant properties of biomaterials in the modulation of cell* Correspondence: amedeocarraro@gmail.com; barbara.zavan@unipd.it
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unless otherwise stated.behavior are not limited to substrate rigidity, topography
or roughness; the density and distribution of adhesive li-
gands, and the chemistry and the substrate elasticity may
also induce the up-regulation of neurogenic, myogenic,
and osteogenic markers in human mesenchymal stem cells
(MSCs) [5].
In the search for brand new factors which may have an
influence on cell behavior, much attention has been re-
cently given to environmental components [6,7], and par-
ticularly on graphene [8]. Graphene is a flat monolayer of
carbon atoms, arranged in a two-dimensional hexagonal
structure [9]. The carbon atom has a valence of four, which
determines the number of possible covalent bonds between
carbon atoms within a molecule. Carbon allotropes differ
according to the types of linkages that form between the
carbon atoms to create macromolecular structures, for ex-
ample rolled graphene sheets represent carbon nanotubes
(CNT), with extraordinary electrical, thermal, and physical
properties. Also, the molecular structure of graphene can
be chemically modified, enabling the attachment of differ-
ent molecules of interest; this feature promotes the devel-
opment of high-performance devices.
Although carbon derivatives have been extensively
employed in industry and electronics, their use in regenera-
tive medicine is still in an early phase [10]. The strategies
developed so far to apply carbon-based nanomaterials toLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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nanomaterials into cell culture media or coating nanoma-
terials for in vitro stem cell culture. The second strategy is
widely accepted to modulate stem cell behaviors since
nanomaterial-coated substrates are able to provide a unique
physical framework, comparable to natural ECM, for stem
cell [11,12]. Graphene can improve the performance of a
broad range of devices and can be used as an “any-shape”
biocompatible single-atomic thick scaffold to enhance stem
cells differentiation thanks to its unique physical, chemical
and mechanical characteristics [13]. Specifically, graphene
is highly biocompatible, has low toxicity and a large dosage
loading capacity, making it a potential efficient carrier for
therapeutic proteins [14].
The exceptional properties of graphene and its poten-
tial different applications have led to the development of
composite materials that include few-layer-graphene
(FLG), ultrathin graphite, graphene oxide (GO), reduced
graphene oxide (rGO), and graphene nanosheets (GNS),
comprising a broad set of “graphene-family nanomater-
ials” (GFNs) (Figure 1) [15-17].
Some of them, like GO substrates, have been already
demonstrated to stimulate human MSCs to differentiate
into adypocites [13,18], to induce the differentiation of
neural stem cells (NSCs) into neurons in three dimen-
sional (3D) porous structure [19] and of induced pluri-
potent stem cells into the endodermal lineage [9]. It wasFigure 1 Representation of some members of the graphene-family nano
oxide (GO) (C), and reduced graphene oxide (rGO) (D) [15].also reported that graphene scaffolds may be considered
as great substrates to induce bone formation from hu-
man MSCs [3]. We further highlight how the properties
of graphene are being exploited for stem cell differenti-
ation in tissue engineering, comprehensively surveying
recent experimental works featuring graphene and gra-
phene derivatives (Table 1).
Graphene and tissue engineering
Osteogenic differentiation
Bone tissue engineering promises to restore bone defects
that are caused by severe trauma, congenital malforma-
tions, etc. Many researchers are studying the ways to
confer a pro-osteodifferentiation or osteoinductive cap-
ability on implants or scaffold materials, where osteo-
genesis of seed cells is promoted. Graphene provides a
new kind of coating material that may confer the pro-
osteodifferentiation capability on implants and scaffold
materials by surface modification. Here, we review re-
cent studies on the effects of graphene on surface modi-
fications of implants or scaffold materials. The ability of
graphene to improve the biological properties of scaffold
materials, and its ability to promote the adhesion, prolif-
eration, and osteogenic differentiation of MSCs or osteo-
blasts have been demonstrated in several studies [20].
Graphene as a coating material for biocompatible sur-
faces has proved to be a positive and safe model tomaterials. Few-layered graphene (A), graphene nanosheet (B), graphene
Table 1 Commitment of stem cells on different graphene substrates
Test substrate Control substrate Cell type Commitment Methods Result Ref.
Glass slides, PET, PDMS, Si/SiO2
coated with graphene sheets




In presence of an osteogenic
medium, graphene coating helps
human MSCs to differentiate to
osteogenic phenotype.
[3]
SiO2 substrate coated with
graphene films






cell proliferation: on graphene
coated substrates the initial
number of cells almost duplicates,
while on the SiO2 substrate it
reaches a factor of 1,5.
[21]
Ti coated with GO sheets Ti Human BMMSCs Osteogenic Immunofluorescence
staining; Implantation
in mouse calvarial defects
The osteogenetic differentiation
of human BMMSCs on Ti/GO
substrate is greatly higher
compared to Ti substrate.
[14]
Graphene and GO films
on PDMS




staining; Oil Red O
staining
Graphene and GO demonstrate
to be effective preconcentration
platform for growth and
differentiation factors. Graphene





GO film Tissue culture polystyrene Human ADSCs Osteogenic; Adipogenic Cell viability assay;
Immunofluorescence
staining; Alizarin Red
staining; Oil Red O
staining
GO film provides a suitable
environment for the adhesion,
proliferation, and differentiation
of human ADSCs. Compared to
tissue culture polystyrene, the
GO film enhances the differentiation
of human ADSCs to osteoblasts
and adipocytes, whereas the GO
film decreases the chondrogenic
differentiation.
[11]




Graphene foam allows viability









Graphene 3D foam has a greater
electrical stimulation performance
when compared to graphene
2D film.
[27]




Graphene coated glass substrate



















Table 1 Commitment of stem cells on different graphene substrates (Continued)
Graphene coated glass Glass Human NSCs Neuronal Immunofluorescence
staining; Electrical
stimulation
Graphene substrate is an excellent
cell-adhesion layer during the
differentiation process and induces
the differentiation of human NSCs
more toward neurons than glial cells.
[19]




NSCs seeded on graphene film
differentiate and form functional
neuronal networks.
[33]
Fluorinated graphene Graphene Human BMMSCs Neuronal Immunofluorescence
staining; AFM imaging;
Fluorinated graphene enhances
cell adhesion and proliferation of
human BMMSCs. It exhibits a
neuro-inductive effect via spontaneous
cell polarization.
[29]
rGO/TiO2 GO/TiO2 and TiO2 Human NSCs Neuronal flash photo stimulation;
Immunofluorescence staining
After flash photo stimulation, human
NSCs proliferate more on rGO/TiO2
that on GO/TiO2 and TiO2. The
neuronal differentiation of human
NSCs on rGO/TiO2 substrate is greatly
higher compared to GO/TiO2 and TiO2
substrate.
[34]
GO Graphene, CNTs Mouse ESCs Neuronal Immunofluorescence
staining; Real time PCR
GO substrate demonstrates an important
enhancement of dopamine neurons
differentiation whereas the GR and the
CNTs do not show any important
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[17]. Kalbacova et al. made the first observations plating
osteoblasts on two different substrates, silica (SiO2) and
graphene-coated SiO2 [21]. After 48 hours incubation the
cells were homogenously covering the graphene substrate,
while appearing as separate spots on the SiO2 surface. The
results were supported by fluorescent imaging, revealing
that in the graphene substrate the initial number of osteo-
blasts almost duplicated, compared to a 1,5 increase factor
in the SiO2 film. Nonetheless, these initial observations
tended to be controversial, considering the study of
Nayak et al. [3]. When graphene was used as a coating
agent on polydimethylsiloxane (PDMS), polyethilenterefta-
late (PET), glass and Si/SiO2, it did not demonstrate to in-
fluence the shape or structure of seeded cells compared to
uncoated surfaces. Furthermore, these authors investi-
gated the osteogenic potential of graphene on MSCs.
MSCs cultured on uncoated Si/SiO2, PDMS and PET sur-
faces showed a CD-44 positive staining and a complete
negative osteocalcin (OCN) staining. On the other hand,
OCN was significantly represented when cells were cul-
tured on the same graphene-coated surfaces (Figure 2).
The results were confirmed by the detection of a greater
extent of calcium deposition in the second cells popula-
tion, confirming the role played by graphene on the induc-
tion of osteogenic differentiation.
Further studies as the one by Lee et al. showed a positive
correlation between culture on graphene substrate and
osteogenic differentiation [13]. In particular, the study re-
vealed the ability of graphene substrates to act as a precon-
centration platform for osteogenic differentiation factors,
such as dexamethasone and beta-glicerophosphate. The
osteogenic differentiation was also visualized by Alizarin
Red staining (Figure 3).
More recently, the alternative coating with GO has
started to be explored. The study by La et al. investi-
gated the potential of GO-coated titanium (Ti) in load-
ing and releasing bone morphogenic protein type 2
(BMP-2) [14]. The osteogenic differentiation of human
bone marrow MSCs (hBMMSCs) cultured on Ti and Ti/
GO substrates was then tested and immunocytochemical
staining for OCN showed a higher osteogenetic potential
at 2 and 3 weeks of hBMMSCs on Ti/GO substrate
compared to Ti substrate without coating. The same
study performed an in vivo validation through implant-
ation of Ti and Ti/GO substrates, with or without BMP-
2, into mice calvaria defects. After a 8 weeks follow up,
micro computed tomography imaging and the histo-
logical analysis confirmed that no new bone formation
was observed without the use of BMP-2, but the Ti/GO/
BMP-2 implant substrates showed a greater bone forma-
tion compared to Ti/BMP-2 substrates.
The osteogenic differentiation potential of MSCs on
graphene substrates was confirmed also by the study ofCrowder et al., where a 3D graphene structure was used
to induce osteogenic differentiation [22]. The authors
remarked that the foam shape structure used was par-
ticularly suitable as a substrate to induce MSCs to differ-
entiate into bone lineage.
The effect of graphene on MSC osteogenic commitment
has been also studied by Duan et al. [23] who compared
carbon nanomaterials (CNMs), such as CNT, with gra-
phene. Their combinations with nanofibrous polymeric
scaffolds, which mimic the morphology of natural ECM of
bone, arouse indeed keen interest in bone tissue engineer-
ing. The hypothesis of the authors was that the sheet-like
graphene might have stronger enhancement in regulating
osteocompatibility than tubular multiwall CNT composite
scaffolds, because the former provided more contacting
surface to cells than the latter when they were at the same
content. Therefore, composite nanofibrous scaffolds were
prepared by using poly-L-lactide (PLLA) and graphene
as starting materials. Briefly, graphenes were added into
PLLA-tetrahydrofuran (THF) solutions, and thermal-
induced phase separation (TIPS) technique was applied to
induce the nanofibrosis of PLLA. To this end, CNMs were
incorporated into nanofibrous PLLA scaffolds by TIPS
technique. The CNMs-containing composite nanofibrous
scaffolds were biologically evaluated by both in vitro
co-culture of hBMMSCs and in vivo implantation. The
nanofibrous structure itself demonstrated significant
enhancement in cell adhesion, proliferation and osteo-
genic differentiation of hBMMSCs, and with the incorpor-
ation of CNMs, the composite nanofibrous scaffolds
further promoted osteogenic differentiation of hBMMSCs
significantly. Between the two CNMs, graphene showed
stronger effect in promoting osteogenic differentiation of
hBMMSCs than CNT. The results of in vivo experiments
revealed that the composite nanofibrous scaffolds had both
good biocompatibility and strong ability in inducing osteo-
genesis. CNMs could remarkably enhance the expression
of osteogenesis-related proteins as well as the formation of
type I collagen. Similarly, the graphene-containing com-
posite nanofibrous scaffolds demonstrated the strongest
effect on inducing osteogenesis in vivo. These findings
demonstrated that CNMs-containing composite nanofi-
brous scaffolds were obviously more efficient in promoting
osteogenesis than pure polymeric scaffolds [23].
The same positive results have been observed by
Tavarty et al. [24] that hypothesized that incorporating
GO with an osteoinductive material could synergistically
direct the differentiation of human MSCs toward osteo-
genic lineage. Calcium phosphates (CaP) such as hy-
droxyapatite (HAp) are biomimetic biomaterials that are
well-recognized for their osteoconductivity (facilitating
bone formation) and osteoinductivity (facilitating the
osteogenic differentiation of human MSCs). To validate
the above hypothesis, the authors synthesized a novel
Figure 2 Immunostaining of MSCs seeded for 15 days in osteogenic differentiation medium on different substrates. Si/SiO2 (A,B), PDMS
(C,D), and PET (E,F) substrates were coated or not with graphene. Cells are stained with DAPI (blue) and OCN (green). MSCs growing on Si/SiO2
(A), PDMS (C), and PET (E) without graphene show OCN negative staining. Once these substrates are coated with graphene (B,D,F respectively),
cells are positive for OCN, indicating osteogenic differentiation. Scale bars are 100 μm [3].
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capability of inducing the osteogenic differentiation in hu-
man MSCs. The GO-CaP nanocomposite was fabricated
using GO microflakes, uniquely structured highly osteoin-
ductive CaP nanoparticles, and pluronics polymeric coat-
ing. The osteoinductive properties of GO microflakes, CaP,
and GO-CaP on human MSCs were evaluated by quantita-
tive measurements on bone nodule formation and the
immunofluorescence imaging of osteoblast biomarkers.
GO-CaP exhibited osteogenic capability that was superior
to individual or combined effects of GO and CaP. To
evaluate the materials’ osteoinductive capability, GO, CaP
and GO-CaP were introduced to human MSCs and their
osteogenic commitment has been evaluated. Results re-
vealed that treatments with GO, CaP and GO-CaP in
osteogenic medium induced significantly larger quantity of
calcium than control at all the time points, while no calcifi-
cation was observed in negative controls. GO-CaP nano-
composites exhibited superior osteoinductivity to CaP orGO, inducing much larger amount of mineralization than
control. Phosphate assay was also performed from the de-
position in parallel plates after 2 and 3 weeks of treatment.
The amount of phosphate among all the groups followed
the sequence of GO-CaP >CaP > >GO> control, consist-
ent with the outcome from calcium quantification. Surpris-
ingly, GO microflakes at low concentration (0,5 mg/mL)
increased calcification up to 50% more than the control at
3 and 4 weeks. The osteogenic differentiation of human
MSCs was verified moreover through immunofluorescence
staining of osteoblast markers: alkaline phosphatase (ALP)
and OCN after 2 weeks of treatments. In good agree-
ments with Alizarin Red staining, ALP activities and
OCN expression level followed the sequence of GO-CaP >
CaP > >GO> control, affirming the potential of GO-CaP
in directing human MSCs differentiation toward osteo-
genic lineage [24].
Owing to the superior mechanical properties and low
coefficient of thermal expansion, graphene has been
Figure 3 Alizarin Red staining of MSCs seeded on PDMS, graphene, and GO substrates. A higher amount of Alizarin Red, which is an
indicator of osteogenic differentiation, is found in MSCs cultured on graphene (C) for 12 days in osteogenic differentiation medium than that
cultured on GO (E) and PDMS (A) in the same conditions. In presence of basal medium, MSCs do not show staining for Alizarin Red in none
of the 3 substrates (B,D,F) [13].
Bressan et al. Journal of Translational Medicine 2014, 12:296 Page 7 of 15
http://www.translational-medicine.com/content/12/1/296widely used in the reinforcement of ceramics. Xie et al.
[25] studied that various ratios of graphene (0,5 wt%,
1,5 wt% and 4 wt%) reinforced with graphene calcium
silicate (CS) for load-bearing implant surface modifica-
tion. Surface characteristics of the graphene-calcium sili-
cate (GC) composite coatings were characterized by
scanning electron microscopy. Results showed that the
graphene plates (less than 4 wt% in the coatings) were
embedded in the CS matrix homogeneously. The sur-
faces of the coatings showed a hierarchical hybrid nano-
microstructure, which is believed to be beneficial to
the behaviors of the cell and early bone fixation of the
implants. Wear resistance measured by a pin-on-disc
model exhibited an obvious enhancement with the adop-
tion of graphene plates. The weight losses of the GC
coatings decreased with the increase of graphene con-
tent. However, too high graphene content (4 wt% or
more) made the composite coatings porous and the wear
resistance decreased dramatically. The weight loss was
only 1,3 ± 0,2 mg for the GC coating containing 1,5 wt%
graphene (denoted as GC1,5) with a load of 10 N and
sliding distance of 500 m, while that of the pure CS
coating reached up to 28,6 ± 0,5 mg. In vitro cytocom-
patibility of the GC1,5 coating was evaluated using
a hBMMSCs culture system. The proliferation and
ALP, osteopontin and OCN osteogenesis-related geneexpression of the cells on the GC1,5 coating did not de-
teriorate with the adoption of graphene. Conversely,
even better adhesion of the hBMMSCs was observed on
the GC1,5 coating than on the pure CS coating. All of
the results indicate that the GC1,5 coating is a good can-
didate for load-bearing implants [25].
Neuronal differentiation
Inducing human NSCs to differentiate into neurons is a
critical challenge to reach an important biomedical goal,
since a promising opportunity in therapies for neural re-
generation could arise [26,27].
Park et al. tested the graphene substrate as a promoter
of human NSCs differentiation into neurons [19]. The
most remarkable data were observed when comparing the
human NSCs seeded on a graphene and a glass substrate
after 30 days. Immunofluorescence showed a greater de-
gree of cell attachment along with cell differentiation rate
into neurons on the graphene substrate, whereas more
glial cells than neurons were found on the glass surface.
The analysis was performed counting the immunopositive
cells for GFAP (a glial cell marker) and TUJ1 (a neuronal
cell marker).
Other results indicating that graphene-based sub-
strates can promote neural differentiation came from the
study by Hong et al. [28]. After culturing PC-12 cells on
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thors observed a better cellular adherence along with
higher cell proliferation and neural differentiation on the
graphene-coated substrate.
In the attempt of influencing in a significant way stem
cell differentiation, several declination of graphene scaf-
folds were studied. Wang et al. tested MSCs on fluorinated
sheets of graphene, observing a strong enhancement of
neuronal differentiation when compared to cells seeded
on graphene [29]. This indicated how fluorinated gra-
phene may be a good engineered platform to enhance
neuronal differentiation. Li et al. used a new 3D scaffold
based on graphene, a graphene foam, which regulated
mice NSCs behavior supporting their growth and keeping
cells at an active proliferation state [27]. Its porous struc-
ture showed to be a good substrate for NSCs adhesion,
probably due to its irregular surface which improved
mechanical adhesion [30]. The scaffold was also proved to
be highly biocompatible since no cytotoxicity was ob-
served and cell viability was not affected. Moreover, the
3D structure had a greater electrical stimulation perform-
ance when compared to a 2D graphene structure, and
electrical stimulation has been proven to induce neural
differentiation [31].
The study by Yang et al. investigated the capability of
GO, graphene and CNTs to induces dopamine neural dif-
ferentiation of mouse embryonic stem cells (ESCs) [32].
ESCs were seeded in all the 3 substrates and a stromal
cell-derived inducing activity method was used. After
14 days of differentiation, the GO substrate demonstrated
an important enhance of dopamine neural differentiation
while the graphene and CNTs did not show any important
promotion of dopamine neural differentiation.
Another important characteristic of graphene could be
represented by its capability to form a functional neural
network. In the study by Tang et al., neurospheres were
seeded on graphene substrates and after a 14 days cul-
ture the process of network formation was made clear
by beta-tubulin immunostaining [33]. Newly formed
neuritis started to form synapses. This result confirmed
how graphene could be considered as a valid substrate
to promote neural activity (Figure 4).
Stimulating human NSCs to differentiate into neurons
rather than glia is a another key point in order to obtain
a neural regeneration result [29]. The study by Akhavan
and Ghaderi specifically concentrated on testing human
NSCs differentiating behavior on different substrates
(TiO2, GO/TiO2, and rGO/TiO2), with and without flash
photo stimulation [34]. When the 3 substrate went
under flash photo stimulation, the number of cells in-
creased by a factor of 1,5 on the rGO/TiO2 substrate, by
a rate of 48% in the GO/TiO2 substrate and by a rate of
24% on the TiO2 substrate. No differences were detected
without flash stimulation. When the differentiation ratewas analyzed it was found that the rGO/TiO2 substrate
was the more beneficiary of the flash photo stimulation:
an 88% decrease in the ratio of glial cells and an 81% in-
crease in the ratio of neuronal cells. In the other 2 sub-
strates the difference was less evident: 25% of neuronal
cells increase rate on the GO/TiO2 substrate and 15% on
the TiO2 substrate. Overall, flash photo stimulation of
graphene-based substrate provide both a greater cell pro-
liferation and a greater human NSCs differentiation into
neurons rather that glia cells. However, these results could
be obtained when the flash photo stimulation of human
NSCs was at an optimum concentration of a biocompat-
ible hole scavenger, and at an optimum flash intensity.
For central nervous system (CNS) regeneration, the
selective differentiation of NSCs into either neurons or oli-
godendrocytes (as opposed to astrocytes) is highly desirable.
Several approaches have been employed to guide differenti-
ation into neurons, however, oligodendrocyte differentiation
has proven to be much more elusive, resulting in only a
small percentage of the differentiated cell population. The
primary approach to guide oligodendrocyte differentiation
has focused on either developing culture media containing
a combination of growth factors or the forced expression of
key oligodendrocyte-promoting transcription factors. In this
view the developing a biomaterials-approach to achieve effi-
cient differentiation of NSCs into mature oligodendrocytes,
while eliminating the potential adverse or variable side-
effects from growth factors and viral gene vectors, would
be highly beneficial.
Shah et al. [35] developed a graphene-based nanomater-
ial for the design of hybrid nanofibrous scaffolds to guide
NSCs differentiation into oligodendrocytes. The authors
demonstrated as the use of GO was an effective coating
material in combination with electrospun nanofibers for
the selective differentiation of NSCs into oligodendrocytes.
By varying the amount of GO coating on the nanofibers,
they observed a GO concentration-dependent change in
the expression of key neural markers, wherein coating
with a higher concentration of GO was seen to promote
differentiation into mature oligodendrocytes. Further in-
vestigation into the role of GO-coating on the nanofibrous
scaffolds showed the overexpression of a number of key
integrin-related intracellular signaling molecules that are
known to promote oligodendrocyte differentiation in nor-
mal development. In their studies, polycaprolactone (PCL)
was electrospun onto a metallic collector and then trans-
ferred to glass substrates for cell culture using a medical
grade adhesive. Nanofibers with an average diameter of
200–300 nm were generated, which is a fiber size range
that has been reported to be favorable for oligodendrocyte
culture, potentially due to the close morphological resem-
blance to axons. Thin-layered GO was then synthesized
and then deposited on the PCL nanofiber surface. Among
the various cell-signaling proteins, the authors examined
Figure 4 Immunostaining of neurospheres deriving from NSCs seeded on graphene films up to14 days. Cells are stained with DAPI (blue)
and beta-tubulin (green) at day 1 (A), day 3 (B), day 7 (C), and day 14 (D). NSCs differentiated on graphene substrates display neurites growing
to various directions and distances, indicating the development of neural networks [29].
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integrin-linked kinase (ILK) and Fyn kinase (Fyn), which
have been found to mediate cytoskeletal remodeling and
process extension during oligodendrocyte development.
The researchers found that NSCs cultured on the GO
coated surfaces enhanced the gene expression of all of
these factors. These signaling molecules exhibited the
same trend in expression, wherein the GO-coated glass
showed higher expression than PCL, and PCL-GO showed
the strongest level of expression with a 2,6-fold increase in
FAK and about a 1,7-fold increase in Akt, ILK and Fyn.
Additionally, treating the cells grown on PCL-GO scaf-
folds with cell signaling inhibitors showed a significant de-
crease in gene expression of mature oligodendrocyte
markers, which provides further evidence for the potential
role of such cellular signaling in the observed oligodendro-
cyte differentiation. Collectively, this data supports the
role of GO-coating in the upregulation of these down-
stream molecules in the integrin signaling pathway and
may explain, at least in part, the enhanced oligodendrocyte
differentiation of NSCs on hybrid scaffolds. Data obtained
suggest that the GO-coating on the nanofiber scaffolds
may promote oligodendrocyte differentiation through
specific microenvironmental interactions which activate
integrin-related intracellular signaling. Overall, Shah et al.
demonstrated the capability of a unique graphene-nanofiber
hybrid scaffold to provide instructive physical cues that lead
to the selective differentiation of NSCs into mature oligo-
dendrocytes, without introducing differentiation inducers inthe culture media. The ability to selectively guide stem
cell differentiation by merely changing the properties
of an underlying biomaterial scaffold is a valuable ap-
proach for tissue engineering, which can help comple-
ment or potentially eliminate the use of exogenous
differentiation. Moreover, their hybrid scaffold is excep-
tional in that it combines the well-established properties
of nanofibers and graphene-based nanomaterials. For
instance, nanofibers have been shown to provide ideal top-
ography for fabricating nerve guidance conduits, directing
neurite outgrowth and promoting axonal regeneration.
On the other hand, graphene-based nanomaterials provide
permissive surfaces for protein and cell adhesion, as well
as high conductivity to mediate electrical stimulation for
supporting neuronal electrophysiology [35].
GO based nanoparticles has been used also to drive the
commitment of ESCs into dopamine neurons. Yang et al.
[36] studied the effects of CNTs, GO and graphene nano-
particles on the dopamine neural differentiation of mouse
ESCs. The dopamine neural differentiation of the ESCs
was examined by immunocytochemistry and real-time
PCR showing that only GO could effectively promote
dopamine neuron differentiation after induction of a stro-
mal cell-derived inducing activity and further enhance
dopamine neuron-related gene expression compared with
cells treated with no nanoparticle control, and the other
two nanoparticles (CNTs and graphene). In conclusion,
authors suggest that GO is a promising nanomaterial-
based technical platform to effectively enhance dopamine
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applied for cell transplantation therapy.
Novel important applications of graphene in neurosci-
ence has been found in the end by Song at al. [37], who
studied the anti-inflammatory effects of three-dimensional
graphene foams cultured with microglial cells. Nanoma-
terials are increasingly used in medical diagnosis and treat-
ment due to their unique mechanical, optical, electrical,
and magnetic properties. However, studies have revealed
that most of the nanomaterials could initiate some form
of inflammation both in vitro and in vivo, then lead to
other biological effects, as expected of any foreign particu-
late. Current studies mostly focus on the pulmonary in-
flammation caused by nanomaterials insults, while little is
known about the neuroinflammatory effects. Given that
some nanomaterials (quantum dots, CNTs, graphene, etc.)
have been attempted to be used in neuroscience, the neu-
roinflammation should be considered. External insults
range from hypoxia and ischemia to a number of bacterial
and viralinfections, all of which elicit a characteristic neu-
roinflammatory reaction in the brain. Microglia, astro-
cytes, and peripheral macrophages are key players
mediating this response. In the brain, most of the damage
caused by nanomaterials is mediated by the microglia, a
macrophage-like, phagocytic cell that is normally inactive
unless confronted by potentially damaging xenobiotics. In
response to certain cues such as brain injury or immuno-
logical stimuli, however, microglia are readily activated.
Graphene has been at the forefront of nanotechnology
and advanced materials sciences due to its intriguing phys-
ical and chemical features. Especially, it has been utilized
in a variety of biomedical applications. Recently, Li et al.
[38] discovered the great potentials of using graphene for
neural interfacing, as it could promote neurite sprouting
and outgrowth in primary culture of hippocampal neu-
rons, enhance the neural performances in the network dif-
ferentiated by NSCs, direct stem cell differentiation, and
be used as electric field stimulator for effective cerebral
blood volume enhancement. Meanwhile, graphene foams
were found to greatly induce NSCs differentiation to neur-
onal lineage and were proposed as a neural scaffold for
NSC-based therapy. These pioneering works demonstrate
the capability of graphene for applications in CNS. How-
ever, to the best of our knowledge, there is no report
regarding the possible neuroinflammatory effects of gra-
phene, which should be well addressed before any further
clinical applications. In this work, the researchers report
the neuroinflammatory responses of microglia under the
presence of graphene by in vitro culturing and justify
whether this graphene-induced neuroinflammatory effects
are detrimental or beneficial to the neural cells. The im-
portance of this work is the elucidation of the pro- and/or
anti-inflammatory effects of graphene and pave the way
for the applications of graphene in biomedicine. Thegraphene, especially 3D graphene, supported microglia
growth and showed comparable biocompatibility to the
commercial tissue culture polystyrene substrates. Despite
of the similar proinflammatory responses in the microglia
without lipopolysaccharide (LPS) activation, 3D graphene
evoked much milder neuroinflammation in the microglia
after LPS activation in comparison to 2D graphene, sug-
gesting that the topographical structures of the materials
might affect the inflammatory behaviors. Furthermore, the
unique topographical structures of 3D-graphene may re-
strict the morphological transformation of microglia under
over-activation, leading to the anti-inflammatory effects.
Adipogenic differentiation
Graphene and GO substrates have been also used for in-
vestigating their effects on the adipogenic differentiation
of MSCs. In particular, in the study of Lee et al., MSCs
were plated on graphene or GO sheets in presence of
adipogenic differentiation medium for 14 days [13]. The
cells were then stained with Oil Red O and counted.
The results showed a strong suppression of adipogenesis
on graphene substrates; on the contrary, GO was a
strong enhancer. This difference was probably due to
the ability of graphene to denaturate insulin: GO did not
denaturate insulin which therefore could maintain its
role of mediator of fatty acid synthesis.
Kim et al. evaluated GO potential in differentiating hu-
man adipose-derived stem cells (ADSCs) into adipocytes,
demonstrating a higher adipogenesis on the GO sub-
strate when compared to the control (tissue culture
polystyrene) [11]. This study also documented how GO
could be considered a unique substrate, allowing the at-
tachment and proliferation of ADSCs and modulating
cell differentiation not only toward the adipogenic line
but also toward the osteogenic and epithelial pheno-
types. On the contrary, the GO films resulted in de-
creased chondrogenic differentiation of the ADSCs.
Periodontal ligament stem cells
In regenerative dentistry, stem cell-based therapy often re-
quires a scaffold to deliver cells or growth factors to the
injured site. GO and silk fibroin (SF) are promising bioma-
terials for tissue engineering as they are both non toxic
and promote cell proliferation. A field that could be im-
proved by the availability of an effective film scaffold
would be the reparation of periodontal tissues. The peri-
odontium, which is composed of four dental tissues (i.e.,
gingiva, alveolar bone, cementum, and periodontal liga-
ment [PDL]), is constantly maintained by periodontal liga-
ment stem cells (PDLSCs) owing to their great capacity of
differentiation into cementoblasts, odontoblasts, and fi-
broblasts. PDL plays a key role in the attachment of teeth
to the jaw; in the most drastic cases of periodontitis, which
is associated with a chronic inflammation process, PDL
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the aim of expanding tissue engineering therapy to as
many patients as possible, acellular biomaterials may be
employed as a novel approach to heal periodontal site by
the active recruitment of autologous cells into the PDL
scaffold, thus providing an in situ regeneration in cases of
periodontitis. So, in order to make the evaluation of the
mentioned SF-GO composite film as scaffold, human den-
tal stem cells were chosen by Rodriguez-Lonzano et al. as
cellular model to test the the performance of GO and SF.
In their study the authors evaluated the effects of the
novel biomaterials GO and SF on PDLSCs phenotype, ad-
hesion, proliferation rate and viability. Biocompatibility of
scaffolds is a prerequisite for generating cell-biomaterial
constructs and for their successful clinical application. GO
and fibroin-based biomaterials have been previously stud-
ied for several tissue engineering based-therapies [39], but
they have never been tested in conjunction with mesen-
chymal stem cells isolated from PDL. The morphology of
PDLSCs cultured for different times on GO and fibroin
coated surfaces by staining of actin cytoskeleton showed
that PDLSCs cultured on fibroin displayed lower amounts
of F-actin, lower spreading and delayed growth. By con-
trast, GO or GO plus fibroin-coated surfaces significantly
improved F-actin content, cell spreading and growth rate
from 96 h of culture when compared to fibroin alone. Fur-
thermore, it has been also studied the proliferation rate of
PDLSCs on GO and fibroin-based biomaterials by MTT
assays. Results confirmed that after 7 days of culture,
PDLSCs showed a high cell proliferation rate in presence
of GO, although it was slightly lower than on plastic,
whereas fibroin or GO-fibroin biomaterials supported a
discrete proliferation. In addition, to evaluate the possible
cellular cytotoxic effect of the different biomaterials
employed as well as changes on the expression of mesen-
chymal surface markers, the researchers characterized
their surface molecule expression pattern by flow cytome-
try. Culture of PDLSCs on fibroin, GO or GO plus fibroin
did not significantly alter the level of expression of CD73,
CD90 or CD105 after 24, 48, 72, 96 or 168 h compared to
expression levels displayed by PDLSCs cultured on plastic.
Thus, the biomaterials employed in this study were able to
maintain the mesenchymal phenotype of PDLSCs.
Cardiomyogenic differentiation
As well reported above, graphene has drawn attention as
a substrate for stem cell culture and has been reported
to stimulate the differentiation of multipotent adult stem
cells. Recently, Lee et al. [40] reported that graphene
enhances the cardiomyogenic differentiation of human
ESCs at least in part, due to nanoroughness of graphene
coated with vitronectin (VN). Human ESCs were cul-
tured on either VN-coated glass or VN-coated graphene
for 21 days. The cells were also cultured on glass coatedwith Matrigel, which is a substrate used in conventional,
directed cardiomyogenic differentiation systems. Results
confirmed that the culture of human ESCs on graphene
promoted the expression of genes involved in the step-
wise differentiation into mesodermal and endodermal
lineage cells and subsequently cardiomyogenic differenti-
ation compared with the culture on glass or Matrigel. In
addition, the culture on graphene enhanced the gene ex-
pression of cardiac-specific extracellular matrices. The
authors concluded in the end that graphene may provide
a new platform for the development of stem cell therap-
ies for ischemic heart diseases by enhancing the cardio-
myogenic differentiation of human ESCs.
The same results have been reched by Park et al. [41]
that demonstrated the use of MSCs culture to promote
cardiomyogenic differentiation. Also in this case gra-
phene exhibited no sign of cytotoxicity for stem cell
culture. MSCs were committed toward cardiomyogenic
lineage by simply culturing them on graphene. The au-
thors speculated that this may be attributed, at least par-
tially, to the regulation of expression levels of ECM and
signaling molecules.
iPSCs
The successful reprogramming of somatic cells into in-
duced pluripotent stem cells (iPSCs) by Takahashi and
Yamanaka in 2006 [42] was seen as a landmark event in
disease research. This new technology promised to pro-
vide a powerful tool for modeling human pathology
that could be used to understand the underlying causes
of various human diseases. The following years saw a
stream of new and improved approaches for converting
somatic cells into more differentiated cell types.
In an interesting study by Yoo et al. [43], the authors
reported that graphene promotes the reprogramming of
mouse somatic fibroblasts into iPSCs.
The generation of ESCs-like cells from somatic cells by
ectopic expression of defined factors is an approach com-
monly known as cell reprogramming. Moreover, because
iPSCs generation is known to be a multiple-step process
mediated by overexpression of the transcription factors
Oct4, Sox2, Klf4, and cMyc, the generation of iPSCs is
very inefficient, and cell reprogramming is considered a
stochastic process in which successive barriers must be
overcome to reach a state of pluripotency. In particular,
one of the first noticeable changes during the reprogram-
ming of somatic fibroblasts is their transformation into
tightly packed clusters of rounded cells in a process that
resembles a mesenchymal-to-epithelial-transition (MET).
More interestingly, recent studies found that microtopo-
graphy substrate affects the MET, improving reprogram-
ming efficiency. The authors examinated whether somatic
fibroblasts should be efficiently reprogrammed into the
pluripotent state on graphene-based substrate. Fitstly they
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spectroscopy, then they studied whether the graphene
substrate enhances cell reprogramming by seeding Oct4-
GFP knock-in (KI) mouse embryonic fibroblasts (MEFs)
onto both the control and graphene-coated substrate in
MEF medium. One day after plating, MEFs were trans-
duced using specific vectors expressing Oct4, Sox2, Klf4,
and cMyc transcription factor. The MEFs plated on the
graphene substrate began to form colonies 10 days after
viral infection, exibiting a significant increase in colonies
undergoing reprogramming on graphene substrate. To
quantify the reprogramming efficiency, they performed
FACS analysis for Oct4-GFP-positive iPSCs derived from
Oct4-GFP KI MEFs in both the control substrate and
graphene-coated substrate. Fifteen days after doxycycline
(dox) induction, the graphene substrate cultures had a sig-
nificant increase in the number of GFP-cells and quantita-
tive real-time PCR analysis showed that pluripotency
marker genes, including Oct4, Nanog, Sox2 and Esrrb
were markedly elevated in graphene-coated substrate cul-
tures compared to uncoated substrate cultures. The pluri-
potent state of graphene-induced iPSCs was assessed by
immunostaining of pluripotency marker. Consistent with
these results, they observed that the graphene-coated sub-
strate significantly increased the number of Oct4, SSEA1
and Nanog colonies. Moreover, in order to analyze the dif-
ferentiation potential of graphene mediated iPSCs, their
capacity for direct differentiation into the cell types of the
three germ layers has been tested. Immunocytochemical
staining and real-time PCR showed that the differentiated
cells were positive. In the end the further developmental
potency of the graphene induced iPSC lines was investi-
gated by SCID mice. Four weeks after injection, teratomas
were readily visible and histological analysis confirmed the
presence of cell types derived from all three embryonic
germ layers validating the pluripotency of these graphene
induced iPS cells. In order to examine whether graphene
substrate affects chromatin state during reprogramming,
they measured the enrichment level of histone modifica-
tions that mark active (histone 3 lysine 4 tri-methylation,
H3K4me3) in the graphene induced cell reprogramming.
Surprisingly, they found a dramatic increase of H3K4me3
expression on graphene substrate and that the transcrip-
tion start sites of Oct4 and Nanog were enriched for
H3K4me3 in graphene surface-induced reprogramming
cultures. Taken together, these results suggest that the
graphene-coated substrate specifically promotes the MET
process in cell reprogramming without affecting the EMT
process. In this study, the autors showed that the epigen-
etic reprogramming of somatic fibroblasts is enhanced on
graphene substrate providing a potential method for the
efficient generation of iPSCs. Interestingly, they found a
specific induction of MET by the graphene substrate dur-
ing reprogramming and an accumulation of H3K4me3,which facilitates increased Oct4 and Nanog occupancy.
These data indicate a unique role for graphene substrates
in facilitating cell reprogramming [43].
Carbon nanoparticles such as zero dimensional (0D) ful-
lerenes, one dimensional (1D) CNTs, and recently two di-
mensional (2D) graphene have been investigated for
applications in therapeutics, bioimaging, and regenerative
medicine. MSCs are currently being widely investigated to
repair, regenerate, and restore damaged tissues. Nanoparti-
cles have been employed to deliver growth factors or genes
into MSCs to manipulate their differentiation [44]. The
development of graphene nanoparticles for MSC applica-
tions necessitates thorough examination of their effects
and interactions with these cells to identify potential
therapeutic doses. To date, very few studies have investi-
gated the cytotoxicity of graphene nanoparticle formula-
tions with specific focus on progenitor cells or MSCs.
Zhang et al. examined the toxicity of graphene quantum
dots, single reduced graphene sheets with diameters in the
range of 5–10 nm, on three progenitor cell types: neuro-
spheres cells, pancreas progenitor cells, and cardiac
progenitor cells [45]. Akhavan et al. employed umbilical
cord-derived MSCs and investigated the size-dependent
cytotoxicity of graphene oxide nanoplatelets and reduced
graphene oxide nanoplatelets (prepared using the modi-
fied Hummer’s method) [46]. Graphene nanoparticles, de-
pending on the synthesis method, can exhibit different
morphologies, chemical properties, and physical proper-
ties. Thus, it is necessary to systematically investigate the
effects that graphene nanoparticles with different morph-
ologies, synthesized by various methods, have on MSC
viability and differentiation. In an interesting study of
Taluktat et al. [44], the dose- and time-dependent effects
were investigated of three graphene nanoparticles on the
viability and differentiation of human MSCs. The initial
cytotoxicity screening over a broad range of concentra-
tions (0–300 μg/mL) and time points (one and three days)
was performed on ADSCs and BMMSCs to identify a range
of potentially safe doses. ADSCs were then employed to
investigate whether these graphene nanoparticles at a
potentially safe low and high dose affect the differential
capabilities of MSCs. The cytotoxicity and differentiation
studies together allowed identification of the range of
doses for the three-graphene nanoparticle formulations
that do not elicit any significantly adverse outcomes on
the viability and differentiation capabilities of MSCs. Results
confirmed that graphene nano-onions (GNOs), graphene
oxide nanoribbons (GONRs), and graphene oxide nanopla-
telets (GONPs) elicited a dose-dependent (0–300 μg/mL),
but not a time-dependent (24 and 72 h) cytotoxic response
on ADSCs and BMMSCs. For all three nanoparticles, con-
centrations of less than 50 mg/mL showed no significant
differences compared to untreated controls. The adipogenic
and osteogenic differentiation potential of ADSCs was not
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or high (50 mg/mL) concentration. GNOs and GONPs
were internalized by ADSCs, while GONRs were not. The
results suggest that GNOs, GONRs, and GONPs at con-
centrations of less than 50 mg/mL for 24 or 72 h could be
considered potentially safe incubation conditions for
ex vivo labeling for MSCs. The results open avenues for use
of these graphene nanoparticle formulations for ex vivo la-
beling of MSCs for applications in regenerative medicine.
Conclusions
The literature on the biological interactions of graphene
family is growing rapidly, and includes studies primarily
motivated by biomedical applications, and environmental
health and safety. As with other biomaterials, the issue of
potential toxicity arises not only in biomedical applications,
but also in non-biomedical products where unintended oc-
cupational, consumer, and environmental exposures can
occur. The exact mechanism of GO and the derived com-
posites in SCs differentiation is still unresolved. It has been
generally hypothesized that the surface characteristics of
graphene family nanomaterials such as nanotopography,
surface stiffness, and large absorption capacity influence
the molecular pathways that control the fate of stem cells.
Both G and GO were reported acting as preconcentrators
for chemicals, proteins and growth factors on their surface
to promote cell differentiation.
In this view, we have reported a review of the inter-
national literature to produce a state-of-the-art update
of graphene applied to tissue engineering and stem cells.
Many studies confirmed that graphene and its related
materials are able to induce human stem cells differenti-
ation into specific lineages. Materials coated with gra-
phene or GO or even 3D graphene foam were capable to
guarantee viability and to induce osteogenic differentiation
of stem cells when compared with traditional substrates or
scaffolds [3,11,13,14,21,22]. In terms of neuronal regener-
ation, graphene and GO showed the same promising dif-
ferentiative potential. Furthermore, a real cellular and
electrical network could be structurally and functionally
created on these materials [19,27-29,32-34]. As well as in
osteogenic and neuronal differentiation, GO can control
adipogenesis [11,13].
Even if we are still uncertain about potential in vivo
applications, mostly due to open questions around tox-
icity, graphene clearly appears to be a step forward in
the field of tissue engineering.
In this light it is interesting the results found by Chen
et al. that express an expert opinion based on sciento-
metric patterns revealed by CiteSpace without prior work-
ing experience in the regenerative medicine field.
Emerging trends and new developments have been identi-
fied based on structural and temporal properties derived
from the relevant publications. The detected surge of thekeyword graphene in the literature of regenerative medi-
cine led the authors to investigate the nature and context
of its use in regenerative medicine. The investigation re-
vealed a rapidly increasing number of studies that specific-
ally used graphene and GO in regenerative medicine
research because of their desirable surface properties for,
among other applications, culturing and maintaining SCs.
Similarly a detected burst of citations provides insightful
guidance for navigating through the fast-changing [47].
There is also an emerging literature on potential
health risks. Despite the popular image of graphene as a
large-area substrate coating, many graphene-family ma-
terials are dry powders at some point in their processing,
and in this form pose the most significant exposure risk
through inhalation. Of particular concern are FLG sam-
ples directly following the thermal exfoliation step or
after washing and drying. There is need for measure-
ment of airborne dust levels in research laboratories,
and in pilot and full-scale manufacturing facilities. GFNs
are high-surface-area materials with corresponding high
potential to cause adsorptive and quenching artifacts in
biological assays [48]. Adsorption on carbon surfaces is
generally favored for molecules with low solubility, par-
tial hydrophobicity, or positive charge (for the common
case of negatively charged GFNs). The biological conse-
quences may include (i) micronutrient depletion, (ii) ar-
tifacts in assays that rely on dye-based molecular probes
(iii) the capacity to carry small molecule drug cargoes,
and (iv) synergistic or antagonistic toxic effects when
GFNs coexist with small molecule toxicants, whose bioa-
vailabilty can be increased or decreased as they partition
to graphene surfaces. More work is needed in this area,
and authors must be skeptical of standard assays without
extensive controls for possible interference. As a final
note,in the area of toxicity, there have been a number of
studies reported, but the field is too young and the lit-
erature too limited to reach conclusions about potential
hazards sufficient for risk assessment or regulation.
Nano-GO has been reported to be biocompatible in a
number of the studies focused on biomedical applica-
tions, at least under the limited conditions covered by
such studies. Other studies have reported adverse bio-
logical responses, including cytotoxicity using human
lung epithelial cells and fibroblasts [49,50]. Cellular up-
take of GFNs has been shown for macrophages and hu-
man lung epithelial cells in some studies although there
have been no studies exploring the mechanism of uptake
and intracellular fate. These sheet-like GFNs may physic-
ally perturb cytoskeletal organization, mitosis, organelle
integrity, and impair cell motility and secretion. A po-
tential toxicity pathway for GFNs is oxidative stress
[51,52] it is not clear whether oxidant generation is re-
lated to reactive edge sites or an indirect response of tar-
get cells to nanomaterials. It is clear that lateral size is a
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deposition and surface area, and surface chemistry has
a large affect on adsorption and dispersibility. Molecular
dyanamics modeling of interactions between GFNs and
cell membranes should provide valuable information about
uptake mechanisms. Systematic investigation of toxico-
logical endpoints using a defined set of carbon nanoma-
terials including carbon black, CNT, and GFNs will be
important to develop structure-activity relations. Because
graphenes form a material family with wide variation in
properties, the graphene-bio field will benefit greatly in
the long run, if its authors show diligence in characterizing
their materials, and describing them according to layer
number, lateral size, surface chemistry rather than ad hoc
sample names.
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